Registered vaccine range for the protection of poultry against various diseases including Infectious Coryza, Egg Drop Syndrome, Salmonella enterididis, Salmonella typhimurium and Pasteurella multocida.
Animal Health Products
Deltamune Manufacturing Facility
Deltamune Manufacturing Facility Vaccination (immunization) is a proven and essential tool in the ongoing fight against animal diseases. At Deltamune, our mission is simple: to enhance food security and improve animal health through high-quality vaccine production. Our state-of-the-art facility is staffed by a skilled and dedicated production team, committed to delivering exceptional results.
Since 2008, we have operated from a modern facility where Good Manufacturing Practice (GMP) principles are fully integrated into every process. Using advanced equipment validated to meet GMP standards, we ensure that each batch undergoes rigorous quality control testing for safety, efficacy, and stability before distribution.
At Deltamune, we prioritize excellence by adhering to strict quality controls at every stage of production. This commitment allows us to consistently exceed expectations and deliver superior products at competitive prices. Our capabilities include commercial vaccines, autogenous vaccines tailored to specific disease outbreaks, and a variety of custom-made solutions to meet the unique needs of our customers.
Registered Vaccines
Indicated for the preventative immunisation of health fowls against infectious coryza. An oil-emulsion of inactivated Avibacterium paragallinarum containing at least 1 x 108 colony forming units per dose of both serotypes A and C.
Indicated for the preventative immunisation of health fowls against infectious coryza and egg drop syndrome (EDS’76). An oil-emulsion of inactivated EDS’76 and Avibacterium paragallinarum containing at least 1 x 108 colony forming units per dose of both serotypes A and C.
An inactivated suspension of Avibacterium paragallinarum, Salmonella Enteritidis and Salmonella Typhimurium. It is indicated for the preventive immunisation of fowls against infectious coryza and infection with Salmonella Enteritidis and Salmonella Typhimurium.
Salmonella Enteritidis is a controlled disease in South Africa according to the Animal Diseases Act, Act 35/1984. In terms of this Act:
(1) Any occurrence or suspected occurrence of Salmonella Enteritidis must be reported immediately to the local state veterinarian.
(2) Poultry and birds may be immunised by the responsible person with an effective remedy.
An inactivated suspension of Pasteurella multocida, Salmonella Enteritidis and Salmonella Typhimurium. It is indicated for the preventive immunisation of fowls against fowl cholera and infection with Salmonella Enteritidis and Salmonella Typhimurium.
Salmonella Enteritidis is a controlled disease in South Africa according to the Animal Diseases Act, Act 35/1984. In terms of this Act:
(1) Any occurrence or suspected occurrence of Salmonella Enteritidis must be reported immediately to the local state veterinarian.
(2) Poultry and birds may be immunised by the responsible person with an effective remedy.
Autogenous Vaccines
Autogenous vaccines are custom, problem-specific vaccines intended for emergency and/or restricted use (time/locality) and are defined as safe non-spreading products derived from specific pathogens isolated from a specific herd/flock of animals/birds and used under veterinary supervision in that specific herd/flock.
The production of autogenous vaccines on contract is offered as a complex service, starting with the development stage right through to production. Autogenous vaccine solutions are provided through veterinarians.
From manufacturing to testing and storage, Deltamune provides our clients with complete support and flexibility in the development of vaccines based on client-supplied specifications. The advantage of this is that a vaccine can be made to address custom, farm specific problems for which there are no other registered, commercial solutions available.
Our dedication to quality ensures compliance with all applicable regulatory standards.
Contract Manufacturing
Deltamune has the ability to produce a variety of biological products and vaccines for the biopharmaceutical industry, in which it supports all phases of testing, development and manufacturing.
This includes contract filling and labelling according to requirements. Some services range from bulk vaccine and substance manufacturing to lyophilisation.
Manufacturing Capabilities:
- Manufacturing of culture media and buffers
- Virus production via cell culture and SPF eggs
- Production of bacterial antigens
- Formulation of vaccines
- Commercial vaccine manufacturing (scale – up to 4 400 bottles per batch)
- Pilot scale vaccine manufacturing (scale – up to 990 bottles per batch)
- Labelling and final packaging
- Contract manufacturing of vaccines and other biological products
- Integrated freeze-dried vaccine manufacturing
- Contract filling and labelling of vaccines.
Research & Development
The Deltamune Research and Development unit is dedicated to the development and evaluation of safe and effective vaccines for diseases of economic importance affecting production animals.
This unit encompasses the Product Development Laboratories and Animal Studies Unit supported by a highly skilled team of veterinarians, paraveterinary professionals, and scientists with specialisations in regulatory affairs, biosecurity, infectious disease epidemiology, bacteriology, virology, micro-, cellular, and molecular biology. The team brings extensive expertise in developing and evaluating bacterial, viral, and mycoplasma vaccines, and laboratory reagents for diagnostics.
The unit operates with state-of-the-art facilities, including regulatory compliant specialist containment laboratories and animal quarantine housing up to Biosafety Level 3 and Vector Protected Facilities. The facilities enable detailed studies of aetiological agents and in vivo evaluation of vaccine candidates in both laboratory and target animal species.
As a widely recognised knowledge leader, Deltamune’s Research and Development unit plays a pivotal role in creating innovative vaccine formulations and reagents for diagnostic tests, delivering cutting-edge biological and testing solutions for production animal health.
Contact us
GENERAL
+27 (0)12 664 5730
+27 (0)86 113 3582
info@deltamune.co.za
.
SALES
+27 (0)12 664 5730
+27 (0)86 113 3582
sales@deltamune.co.za
Part of the PHATISA Group